Home » Topics » BioWorld Science

BioWorld Science
RSS

PGC-1alpha as a novel therapeutic target in sickle cell disease

Jan. 2, 2020

Phase I data presented for ambrisentan in sickle cell disease

Jan. 2, 2020

Autolus presents phase I data from Amelia study of AUTO-3 in pediatric patients

Jan. 2, 2020

Metformin, explained

Jan. 2, 2020

Anthos Therapeutics studies MAA-868 in phase II for atrial fibrillation

Dec. 31, 2019

CTX-712: a novel promising CLK inhibitor for myeloid tumors

Dec. 31, 2019

BioXcel begins phase III program with BXCL-501 for agitation in schizophrenia and bipolar disorder

Dec. 31, 2019

FDA approves OncoImmune's IND for anti-CTLA-4 antibody ONC-392

Dec. 31, 2019

Hookipa begins dosing in phase I/II trial of HB-201 for HPV16-positive cancers

Dec. 31, 2019

New phase Ib study evaluates mavorixafor with ibrutinib for Waldenstrom's macroglobulinemia

Dec. 31, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...